[1] Cheah CY,Campbell BA,Seymour JF. Primary breast lymphoma[J].Cancer Treat Rev,2014,40(8):900-908. [2] Hosein PJ,Maragulia JC,Salzberg MP, et al.A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era[J].Br J Haematol,2014,165(3):358-363. [3] Thomas A,Link BK,Altekruse S,et al.Primary breast lymphoma in the United States:1975-2013[J].J Natl Cancer Inst,2017,109(6):1-8. [4] Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J].Blood,2004,103(1):275-282. [5] Shao YB,Sun XF,He YN,et al.Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature[J].Med Oncol,2015,32(2):448-553. [6] Telesingle PU,Anthony PP.Primary lymphoma of the breast[J].Histopathology,1985,9(3):297-307. [7] Hugh JC,Jackson FI,Hanson J,et al.Primary breast lymphoma.An immunohistologic study of 20 new cases[J].Cancer,1990,66(12):2602-2611. [8] Bicchierai G,Rigacci L,Miele V,et al.Role of core needle biopsy in primary breast lymphoma[J]. Radiol Med,2017,122(9):651-655. [9] Jennings WC,Baker RS,Murray SS,Howard CA,et al.Primary breast lymphoma:the role of mastectomy and the importance of the importance of lymph node status[J].Ann Surg,2007,245(5):784-789. [10] Radkani P,Joshi D,Paramo JC,et al.Primary breast lymphoma:30 years of experience with diagnosis and treatment at a single medical center[J].JAMA Surg,2014,149(1):91-93. [11] Uesato M,Miyazawa Y,Gunji Y,et al.Primary non-Hodgkin's lymphoma of the breast:report of a case with special reference to 380 cases in the Japanese literature[J].Breast Cancer,2005,12(2):154-158. [12] Yhim HY,Kim JS,Kang HJ,et al.Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy[J].Int J Cancer,2012,131(1):235-243. [13] Wei ZL,Huang DP.Advances in diagnosis and treatment of primary breast lymphoma -Review[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2017,25(2):604-607. [14] Avilés A,Delgado S,Nambo MJ,et al.Primary breast lymphoma:results of a controlled clinical trial[J].Oncology,2005,69(3):256-260. [15] Ryan G,Martinelli G,Kuper-Hommel M,et al.Prinary diffuse large B-cell lymphoma of the breast:prognostic fators and outcomes of a study by the Intemational Extranodal Lymphoma Study Group[J].Ann Oncol, 2008,19:233-241. [16] Cahan B,Chen YJ.Modern radiation therapy for extranodal lymphomas:field and dose guildlines from the International Lymphoma Radiation Oncology Group[J].Int J Radiat Oncol Biol Phys,2015,93(2):471-472. [17] Weiler-Sagic M,Bushelev O,Epelbaum R,et al.(18)F-FDG avidity in lymphoma readdressed:a study of 766 patients[J].J Nucl Med,2010,51(1):25-30. [18] 单冬勇,曹科,宾石珍,等.鼻腔NK/T细胞淋巴瘤行全脑全脊髓照射的放疗计划设计[J].中国医学物理学杂志,2016,33(2):177-180. |